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The new coronavirus disease (COVID-19) carries a high risk of infection and has spread 
rapidly around the world. However, there are limited data about the clinical symptoms globally. 
The purpose of this systematic review and meta-analysis is to identify the prevalence of the 
clinical symptoms of patient with COVID-19. 
Methods 
A systematic review and meta-analysis were carried out. The following databases were 
searched: PubMed, CHINAL, MEDLINE, EMBASE, PsycINFO, MedRxiv and Google Scholar, 
from December 1st 2019 to January 1st 2021. Prevalence rates were pooled with meta-analysis 
using a random-effects model. Heterogeneity was tested using I-squared (I2) statistics.  
Results 
A total of 215 studies, involving132,647 COVID-19 patients, met the inclusion criteria. 
The pooled prevalence of the 4 most common symptoms were fever 76.2% (n = 214; 95% CI 
73.9-78.5); coughing 60.4% (n = 215; 95% CI 58.6-62.1); fatigue 33.6% (n = 175; 95% CI 31.2-
36.1); and dyspnea 26.2% (n = 195; 95% CI 24.1-28.5). Other symptoms from highest to lowest 
in terms of prevalence include expectorant (22.2%), anorexia (21.6%), myalgias (17.5%), chills 
(15%), sore throat (14.1%), headache (11.7%), nausea or vomiting (8.7%), rhinorrhea (8.2%), 
and hemoptysis (3.3%). In subgroup analyses by continent, it was found that 4 symptoms have a 
slight prevalence variation - fever, coughing, fatigue and diarrhea. 
Conclusion 
This meta-analysis found the most prevalent symptoms of COVID-19 patients were 
fever, coughing, fatigue and dyspnea. This knowledge might be beneficial for the effective 
treatment and control of the COVID-19 outbreak. Additional studies are required to distinguish 










At the end of December 2019, a new coronavirus disease (COVID-19) emerged in 
Wuhan City, Hubei province, China, and subsequently spread worldwide (Li et al., 2020). 
COVID-19 is a serious threat to human health. On 30th January, 2020, the World Health 
Organization (WHO) declared a public health emergency and named COVID-19 a pandemic 
(World Health Organization, 2020). Almost all countries and regions around the world have 
reported confirmed cases of COVID-19. Globally, the WHO reported more than 165 million 
confirmed cases worldwide, with nearly 3 million deaths as of 22nd May, 2021 (WHO, 2021). 
Identifying the main clinical symptoms is essential for early detection and for the isolation of 
infected patients. 
A large number of studies have been published aiming to identify the clinical features of 
COVID-19. Several systematic reviews and meta-analyses have been published which have 
assessed the prevalence of baseline clinical characteristic and associated factors (Fu et al., 2020; 
Ghayda et al., 2020; Grant et al., 2020; Li, Huang, et al., 2020; Rodriguez-Morales et al., 2020; 
Sun et al., 2020; Wan et al., 2020; Yang et al., 2020; Zhu et al., 2020). While such reviews are 
helpful, they have included relatively few studies. Moreover, a limitation was observed in those 
reviews in terms of geographical location and the sample characteristics included. Even though 
there have been a large number of publications, there is a need for an in-depth understanding of 
the clinical symptoms of COVID-19 which can help in tackling this pandemic and preventing 
future outbreaks of infectious diseases. Therefore, the aim of this study was to conduct a 
systematic review and meta-analysis to assess the prevalence of the symptoms associated with 
COVID-19. 
Methods 






A systematic literature search for the period between December 1st 2019 and January 1st 
2021, was conducted using the following databases: PubMed, CHINAL, MEDLINE, EMBASE, 
PsycINFO, MedRxiv, and Google Scholar. Search terms used both free text words and medical 
subject headings, i.e. MeSH terms, to search for papers to be included in the review; that is (MH 
" COVID-19") OR (MH " coronavirus disease 2019") OR (MH " severe acute respiratory 
syndrome coronavirus 2") OR (MH " SARS-CoV-2") OR (MH "2019 novel coronavirus ") OR 
(MH "2019-nCoV") OR (MH "coronavirus") OR (MH "corona virus") OR "Wuhan 
pneumonia"OR "COVID " OR "Betacoronavirus" OR "Alphacoronavirus" OR "coronavir*" 
AND (MH "clinical characteristics") OR (MH " symptomatology") OR (MH " Features") OR 
(MH "Symptom*") OR "signs ". In addition, the reference lists of the retrieved studies and 
review articles were screened to identify any further studies. 
Study Selection  
Two investigators (MM; SM) performed the search, scrutinizing all titles and abstracts 
for eligibility against the inclusion and exclusion criteria. Any disagreements were resolved by 
discussion with a third investigator (KB). Studies were included in the review based on the 
following inclusion criteria: (1) diagnosed with COVID-19; (2) reported prevalence of clinical 
symptoms; (3) subjects aged 15 or older; (4) all types of settings; (5) cross-sectional or cohort 
surveys (only the baseline data were extracted); and (6) sample size greater than 40 to avoid 
selection bias from small studies. The exclusion criteria were: (1) protocol papers, and 
conference abstracts; and (2) case reports and studies with a sample size of less than 40. For any 
additional information, the study authors were contacted. 
Quality Assessment 
Upon retrieval of the applicable studies, quality assessment was completed using the 
Newcastle-Ottawa Scale (NOS; Well et al., 2020). This scale consists of 8 items that evaluate 




of study groups, and outcome assessment. The NOS uses a score system with the lowest possible 
score of 0 and the highest possible score of 9. The total points awarded indicate the overall 
quality of the study. A study was determined to be of low risk of bias when the score was 7-9, of 
moderate risk of bias if the score was 5-6, and of high risk of bias if the score was 0-4 (Li & 
Katikireddi, 2019).  
Data Analyses 
The mean point of prevalence, the odds ratio (OR) with a 95% Confidence Interval (CI), 
was calculated as the effect size by using a random-effects model. Heterogeneity was tested 
using I-squared (I2) statistics. A value of I2 was considered to be low in terms of heterogeneity 
with 0-25%, moderate with 25-50% and high with 50-75% (Higgins et al., 2003). The variation 
in terms of the prevalence of continent, NOS, and month of conducting the study, were assessed 
by subgroup analyses if there were more than 4 studies in a subgroup. Meta-regression analyses 
were performed for moderating continuous variables (mean age, male gender, and 
comorbidities). A sensitivity analysis was performed by removing one study at a time to evaluate 
the impact of the pooled prevalence of the remining studies (Patsopoulos et al., 2008).  
Publication bias was estimated using Egger’s linear regression test (Egger et al., 1997). A 
p value of less than 0.05 was considered as indicating statistical significance. Meta-analysis was 
conducted using the Comprehensive Meta-Analysis software, version 2.2 (Englewood, New 
Jersey, USA). Forest plots were constructed using a Microsoft Excel spreadsheet constructed by 
Neyeloff et al. (Neyeloff et al., 2012). 
Results 
The database search identified 4,365 papers. Of these, 4,018 papers were excluded during 
the title and abstract screening process. A further 132 papers were excluded during full text 
review for the following reasons: 34 papers were not conducted during the COVID-19 period; 9 




letter papers. As such, 215 studies were identified as being eligible for meta-analysis (Figure 1 
shows the PRISMA flow chart). 
General Characteristics  
Two hundred and fifteen studies, involving 132,647 COVID-19 patients, were included 
in this meta-analysis. All studies were conducted between January 2020 and June 2020: 7 in 
January, 112 in February, 50 in March, 28 in April, 15 in May, and 3 in June. Seventeen preprint 
studies (Chen et al., 2020; Chen et al., 2020; Duan et al., 2020; Fu et al., 2020; Kuang et al., 
2020; Li, Zhang, et al., 2020; Liu et al., 2020; Nie et al., 2020; Qi et al., 2020; Qi et al., 2020; 
Qin et al., 2020; Shi et al., 2020; Song et al., 2020; Tao et al., 2020; Wen et al., 2020; Xu et al., 
2020; Zhao et al., 2020) were included in the analysis. All the studies included in this meta-
analysis were of retrospective design. The vast majority (n = 208 studies) used polymerase chain 
reaction (PCR) to diagnose COVID-19 and 2 studies (Ke et al., 2020; Xie et al., 2020) used a 
combination of PCR and antibody tests. Five studies (Chen et al., 2020; Han et al., 2020; Xiao et 
al., 2020; Zheng et al., 2020; Zhou et al., 2020) did not give information about diagnostic 
criteria.  
One hundred and fifty-one studies originated from China, 16 from the USA, 6 from 
Spain, 5 from Iran, 4 each from Italy, Korea, and the UK, 3 each from Belgium, France, the 
Kingdom of Saudi Arabia and Kuwait, 2 from Jordan, and 1 from each of the following: 
Bangladesh, Bulgaria Canada, Germany, Japan, Netherlands, Pakistan, Poland, Singapore, 
Somalia and Turkey (See Supplementary Table 1 for the general characteristics of the studies). 
Quality Assessment 
The studies were assessed using the NOS checklist. Thirty-nine studies were classified as 
having a low risk of bias, and 166 as moderate risk. The detailed results of the quality assessment 




Demographic and Comorbidity Characteristics 
The mean age of patients among 191 studies was 54.26 years (95% CI 52.64-55.87). All 
meta-analyses of prevalence estimates that in terms of the gender distribution of COVID-19, 
male patients accounted for 53.1% (71,194/132,546 participants, 95% CI 51.9-54.2). One 
hundred and ninety-three studies provided information about comorbidities. The most frequent 
comorbidities among patient were hypertension 26.8% (32,925/93,909 participants, 95% CI 
24.7-29.1), followed by diabetes with 13.4% (18,372/124,199, 95% CI 12.4-14.4).   
Fever 
Fever was estimated to occur in 214 studies. The overall pooled point estimates of 
prevalence for fever varied between 7.5% and 99.1%. All meta-analyses of prevalence estimates 
of fever reported by the 214 studies yielded a summary prevalence of 76.2% (84,823/132,436 
participants, 95% CI 73.9-78.5) (Figure 2) (See Table 1). In the subgroup analyses by continent 
in terms of where the study was conducted, the pooled prevalence of fever was 71.7% in Asia, 
68.2% in Europe, and 51.5% in North America. The pooled prevalence of fever was highest in 
February (82.5%) followed by January with 81.2% in (See Table 2). 
Coughing  
Coughing was identified in 215 studies. The overall pooled point estimates of the 
prevalence of coughing varied between 16% and 93.3%. All meta-analyses of prevalence 
estimates of coughing reported by the 215 studies yielded a summary prevalence of 60.4% 
(73,778/132,647 participants, 95% CI 58.6-62.1). A subgroups analysis by continent showed a 
coughing prevalence of 57.7% for North America, 54.7% for Asia, and 49% for Europe. 
Fatigue  
Fatigue was estimated in 175 studies. The overall pooled point estimates of prevalence 
for fatigue varied between 3.4% and 90.6%. All meta-analyses of prevalence estimates of fatigue 




95% CI 31.2-36.1). The pooled prevalence rates with regard to fatigue were 45.7% for Europe, 
36.7% for North America, and 31.7% for Asia. 
Dyspnea  
Dyspnea was estimated in 195 studies. The overall pooled point estimates of prevalence 
for dyspnea varied between 1% and 99%. All meta-analyses of the prevalence estimates of 
dyspnea reported by the 195 studies yielded a summary prevalence of 26.2% (46,681/127,715 
participants, 95% CI 24.1-28.5). In the subgroup analyses by continent, the pooled prevalence of 
dyspnea was 42.4% for Europe, 41.6% for North America, and 22.5% for Asia. The pooled 
prevalence of dyspnea was highest in May (34.6%). In meta-regression analyses, the mean age 
and patients with respiratory disease were significantly associated with the dyspnea prevalence 
rate (p < 0.001). 
Expectorant  
Expectorant was estimated in 102 studies. The overall pooled point estimates of 
prevalence for expectorant varied between 2.2% and 56.5%. All meta-analyses of prevalence 
estimates of expectorant reported by the 102 studies yielded a summary prevalence of 22.2% 
(14,159/65,275 participants, 95% CI 20.1-24.4). A subgroups analysis by continent showed the 
expectorant prevalence of 29.8% for Asia and 17.5% for Europe. 
Anorexia 
Anorexia was estimated in 63 studies. The overall pooled point estimates of prevalence 
for anorexia varied between 3% and 86%. All meta-analyses of prevalence estimates of anorexia 
reported by the 63 studies yielded a summary prevalence of 21.6% (4,126/19,004 participants, 
95% CI 18-25.8). In the subgroup analyses, the prevalence of anorexia was highest reported by 
most commonly found in studies from Europe with 39.5% compared to 20% for studies 
conducted in Asia. The male gender, hypertension and liver disease patients were significantly 





Myalgias was estimated in 130 studies. The overall pooled point estimates of prevalence 
for myalgias varied between 0.8% and 65.3%. All meta-analyses of prevalence estimates of 
myalgias reported by the 130 studies yielded a summary prevalence of 17.5% (16,762/91,491 
participants, 95% CI 15.3-19.8). In the subgroup analyses, the prevalence of myalgias was 
similarly reported by studies from Europe (36.7%) and North America (26.6%), whereas it was 
lower in Asia (15.4%). The pooled prevalence of myalgia was highest in April (30.6%). 
Chills 
Chills were estimated in 45 studies. The overall pooled point estimates of prevalence for 
chills varied between 1.6% and 53.3%. All meta-analyses of the prevalence estimates of chills 
reported by the 45 studies yielded a summary prevalence of 15% (2,728/17,303 participants, 
95% CI 11.9-18.6).  
Sore Throat 
Sore throat was estimated in 80 studies. The overall pooled point estimates of prevalence 
for sore throat varied between 1.2% and 57.4%. All meta-analyses of prevalence estimates of 
sore throat reported by the 80 studies yielded a summary prevalence of 14.1% (5,389/41,810 
participants, 95% CI 11.6-16.9). In the subgroup analyses, the highest prevalence of sore throat 
was in Europe (24.1%) and North America (21.6%) compared to studies conducted in Asia 
(12.3%). Pooled prevalence of sore throat was highest in April (25.4%). 
Headache  
Headache was estimated in 141 studies. The overall pooled point estimates of prevalence 
for headache varied between 1.5% and 75%. All meta-analyses of prevalence estimates of 
headache reported by the 141 studies yielded a summary prevalence of 12.1% (9,164/63,999 




prevalence of 27.1% for Europe, 23.7% for North America, and 10.2% for Asia. The month of 
April showed the highest prevalence of headache (25.6%).  
Diarrhea  
Diarrhea was estimated in 186 studies. The overall pooled point estimates of prevalence 
for diarrhea varied between 1% and 50.3%. All meta-analyses of prevalence estimates of 
diarrhea reported by the 186 studies yielded a summary prevalence of 11.7% (14,008/95,345 
participants, 95% CI 10.7-12.8). The prevalence of diarrhea in North America was 18.3%, in 
Europe 16.8%, and in Asia 16.7%. Male patients were significantly associated with the 
prevalence of diarrhea symptoms (p = 0.03). 
Nausea or Vomiting  
Nausea or vomiting was estimated in 95 studies. The overall pooled point estimates of 
prevalence for nausea or vomiting varied between 1% and 96.3%. All meta-analyses of 
prevalence estimates of nausea or vomiting reported by the 95 studies yielded a summary 
prevalence of 8.7% (4,093/41,319 participants, 95% CI 7.1-10.5). A subgroups analysis by 
continent showed that nausea or vomiting prevalence were highest North America (20.1%), 
compared to Europe (13.3%) and Asia (7.1%). In meta-regression analyses, patients with 
cardiovascular, renal and cerebrovascular disease were significantly associated with the nausea 
or vomiting prevalence rate (p < 0.001). 
Rhinorrhea 
Rhinorrhea was estimated in 76 studies. The overall pooled point estimates of prevalence 
for rhinorrhea varied between 0.2% and 60.1%. All meta-analyses of prevalence estimates of 
rhinorrhea reported by the 76 studies yielded a summary prevalence of 8.2% (3,452/30,150 
participants, 95% CI 6.2-10.6). In the subgroup analyses, the prevalence of rhinorrhea was 






Hemoptysis was estimated in 41 studies. The overall pooled point estimates of prevalence 
for hemoptysis varied between 0.1% and 41.4%. All meta-analyses of the prevalence estimates 
of hemoptysis reported by the 41 studies yielded a summary prevalence of 3.3% (12,578/49,942 
participants, 95% CI 1.8-6.2).  
Sensitivity Analysis 
Sensitivity analysis was conducted with regard to all subgroups by excluding one study 
each time.  This demonstrated that there were no differences in the overall estimation by more or 
less than 1%. 
Publication Bias 
Publication bias was assessed using Egger’s regression test. Evidence of bias was found 
with regard to the following: Coughing (n = 215; p < 0.001); Fever (n = 214; p < 0.001); 
Dyspnea (n = 195; p < 0.001); Diarrhea (n = 186; p < 0.001); Fatigue (n = 175; p = 0.01); 
Headache (n = 141; p < 0.001); Nausea or Vomiting (n = 95; p < 0.001); Sore Throat (n = 80; p 
= 0.01); Rhinorrhea (n = 76; p < 0.001); Hemoptysis (n = 41; p < 0.001). On the other hand, 
Chills (n = 186; p = 0.15); Myalgias (n = 130; p = 0.15); Expectorant (n = 102; p = 0.37) and 
Anorexia (n = 63; p = 0.18) did not show the presence of publication bias. 
Discussion  
COVID-19 is viewed as a major threat to public health due to the incredible damage it is 
doing to the medical services and the economies of almost all countries across the global 
(Wiebers & Feigin, 2020). Given that it is a new infectious disease, assessing the clinical signs 
and symptoms of COVID-19 is imperative for early detection and for the isolation of infected 
patients in order to reduce the spread of the disease, and to identify appropriate management 
strategies. This meta-analysis has been undertaken to estimate the aggregate prevalence of 




This meta-analysis found that there was a minor variation in terms of COVID-19 patients 
between male (53.7%) and female (46.3%). This is consistent with other meta-analyses that have 
found that there were slightly more male than female patients (Li, Huang, et al., 2020; Zhu et al., 
2020). However, in contrast, a meta-analysis conducted by Peckham et al. (2020) involving 
3,111,714 subjects, found no difference with regard to the number of males and females with 
COVID-19. This difference might be linked to sex hormones and X-linked genes that may 
inactivate immunity with regard to responses (Agrawal et al., 2020). Clearly, the gender disparity 
with regard to COVID-19 is not fully understood.   
In this meta-analysis, the most frequently-reported clinical features of COVID-19 were 
fever, coughing, fatigue, and dyspnea (76.2%, 60.4%, 33.6%, and 26.2% respectively). These 
results are lower by between approximately 5% and 20% compared to other meta-analyses (Fu et 
al., 2020; Ghayda et al., 2020; Grant et al., 2020; Li, Huang, et al., 2020; Rodriguez-Morales et 
al., 2020; Sun et al., 2020; Wan et al., 2020; Yang et al., 2020; Zhu et al., 2020). For example, 
Yang et al. (2020) undertook a meta-analysis of 7 studies which included 1,576 COVID-19 
patients, and found: fever (91%), coughing (67%), fatigue (51%), and dyspnea (30%). This could 
be explained by this meta-analysis including a relatively small sample of COVID-19 patients 
ranging from 656 (Rodriguez-Morales et al., 2020) to 50,466 (Sun et al., 2020). In contrast, the 
meta-analysis reported in this paper involved 132,647 COVID-19 patients, which might have 
caused these differences in symptom prevalence. Another possible reason is that 3 reviews 
(Ghayda et al., 2020; Li, Huang, et al., 2020; Zhu et al., 2020) included pediatric COVID-19 
patients in their analysis. Ding et al. (2020) conducted a meta-analysis with 387 children 
diagnosed with COVID-19 and reported the prevalence of symptoms as follows: fever 51.2%, 
coughing 37%, dyspnea 4%, all of which are less frequent than is the case with adult patients. In 




The results of the current meta-analyses are even lower when compared with studies 
which reported symptoms at onset of fever, coughing, fatigue and dyspnea for the Middle East 
Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) epidemics 
(Assiri et al., 2016; Azhar et al., 2019; Cleri et al., 2010; Yin & Wunderink, 2018; Zhao et al., 
2003). Furthermore, in sub-group analyses by continent, differences were found in the reported 
prevalence of symptoms. Studies conducted in Asia reported the highest prevalence of fever, 
expectorant, chills and hemoptysis. In Europe, fatigue, dyspnea, anorexia, myalgias, sore throat 
and headache were ranked as the most prevalent, whereas studies conducted in North America 
reported the highest prevalence of coughing, nausea or vomiting, and rhinorrhea. The prevalence 
of diarrhoea was approximately the same in three continents. This variation of the symptoms 
between continents may be explained by variations between the patients in terms of social 
conditions, environment, and geographical location. 
The findings of this analysis suggested that 4 symptoms have slight variations in 
prevalence between the continents - fever, coughing, fatigue and diarrhea. However, it is 
recommended that every country should have its own symptoms list to evaluate patients.    
The meta-regression analysis also revealed that male patients were significantly 
associated with a pooled estimation of anorexia, diarrhea, and nausea or vomiting. In addition, 
mean age and respiratory disease yielded a higher prevalence of dyspnea. These finding warrant 
further examination.  
The major strength of this meta-analysis is the large sample size of over 132,647 subjects 
drawn from 215 studies which estimated the symptom onset of patients diagnosed with COVID-
19. However, there are several potential limitations to this meta-analysis. First, this review 
searched medRxiv’s preprint studies which, at the time of searching, were not peer reviewed. 
This might introduce publication bias. Second, there is a possibility that some studies have not 




several databases. In addition, only studies published, unpublished or translated into English 
were included in this analysis. Third, around 151 of the studies originated from China, while the 
other 64 studies originated from 22 countries. Two studies from Spain included 25,615 subjects. 
Fourth, there were insufficient data available with regard to the demographic and clinical 
characteristics, so not all information could be eliminated thoroughly. Finally, all findings were 
derived from retrospective designs, which means that we cannot rule out selection bias.  
This is a systematic review and meta-analysis reporting pooled estimates with regard to 
the prevalence of symptoms associated with COVID-19. Thus, the findings can be used to help 
healthcare professionals and policy makers identify and monitor patients as part of the early 
screening process of COVID-19 patients. This might help ensure the appropriate utilization of 
healthcare resources, which in turn might help to reduce the severity of the impact of COIVD-19 
and be beneficial when it comes to effective management and treatment. 
Conclusion 
This meta-analysis has been undertaken to estimate the aggregate prevalence of the 
clinical signs and symptoms of COVID-19 patients. This meta-analysis found that the most 
prevalent symptoms with regard to COVID-19 patients were fever, coughing, fatigue and 
dyspnea. This knowledge might be beneficial for the effective treatment and control of the 
COVID-19 pandemic. Additional studies are required to distinguish between symptoms during 
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Age 191   54.26 52.6-55.8    
Male 214 71194 132546 53.1 51.9-54.2 93 1 0.11 
         
Comorbidities         
Hypertension 171 32925 93909 26.8 24.7-29.1 98.2 1 0.000 
Diabetes 182 18372 124199 13.4 12.4-14.4 95.4 0.5 0.02 
Cardiovascular 173 19086 123321 9.8 8.5-11.1 98.4 0.5 0.000 
Respiratory 163 9475 114861 6 5.3-6.9 96.9 0.5 0.000 
Renal 161 5434 111313 3.6 3-4.4 97.4 0.5 0.009 
Liver 110 8966 103151 3.2 2.2-4.5 99.1 0.5 0.000 
Malignancy 125 4863 100506 3.4 2.8-4 96.5 0.5 0.000 
Cerebrovascular 77 3685 38468 5.4 4.1-7 97.9 0.5 0.000 
         
Fever 214 84823 132436 76.2 73.8-78.5 98.9 1 0.000 
Cough 215 73778 132647 60.4 58.6-62.1 97.2 0.5 0.000 
Fatigue 175 28306 78973 33.6 31.2-36.1 97.7 1 0.01 
Dyspnoea 195 46681 127715 26.2 24.1-28.5 98.6 0.5 0.000 
Expectorant 102 14159 65275 22.2 20.1-24.4 97 0.5 0.76 




Myalgias 130 16762 91491 17.5 15.3-19.8 98.3 0.5 0.29 
Chills 45 2728 17303 15 11.9-18.6 97.1 1 0.3 
Sore Throat 80 5389 41810 14.1 11.6-16.9 97.8 1 0.02 
Headache 141 9164 63999 12.1 10.3-14.3 98 1 0.00 
Diarrhoea 186 14008 95345 11.7 10.7-12.8 96.1 0.5 0.000 
Nausea or Vomiting 95 4093 41319 8.7 7.1-10.5 97 0.5 0.000 
Rhinorrhea 76 3452 30150 8.2 6.2-10.6 97.9 1 0.00 
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1 (T. Zhu et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
2 (L. Shi et al., 2020) 1 1 0 1 1 1 1 0 6 Moderate 
3 (Jiangshan Lian et 
al., 2020) 
1 1 0 1 1 1 1 0 6 Moderate 
4 (Q. Yang et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
5 (X.-W. Xu et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
6 (S. Shi et al., 2020) 1 1 0 1 1 1 1 0 6 Moderate 
7 (Tenforde et al., 2020) 1 1 0 1 1 1 1 0 6 Moderate 
8 (Duanmu et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
9 (Bernheim et al., 
2020) 
1 1 1 1 1 1 1 0 7 Low 
10 (Wei et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
11 (Suleyman et al., 
2020) 
1 1 1 1 1 1 1 0 7 Low 
12 (TieLong Chen et al., 
2020) 
1 1 0 1 1 1 1 1 7 Low 
13 (D’Silva et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
14 (Yuchen Chen et al., 
2020) 
1 1 0 1 1 1 1 0 6 Moderate 
15 (Covino et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
16 (Q. Shi et al., 2020a) 0 1 1 1 1 0 1 0 5 Moderate 
17 (H. Xu et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
18 (S. Liu et al., 2020) 1 1 0 1 1 1 1 0 6 Moderate 
19 (Tao Chen et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
20 (Dawei Wang et al., 
2020a) 
1 1 1 1 1 1 1 0 7 Low 
21 (J.-J. Zhang et al., 
2020b) 
1 1 0 1 1 1 1 0 6 Moderate 
22 (Qingqing Chen et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
23 (F. Zheng et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
24 (H. Zhang et al., 2020) 1 1 0 1 1 1 1 0 6 Moderate 
25 (Tao Li et al., 2020g) 1 1 1 1 1 1 1 0 7 Low 
26 (Colaneri et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
27 (Guan et al., 2020b) 1 1 1 1 2 1 1 0 8 Low 




29 (F. Wu et al., 2020) 1 1 0 1 1 1 1 0 6 Moderate 
30 (Xiao et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
31 (Guo et al., 2020) 1 1 0 1 1 1 1 0 6 Moderate 
32 (Y. Deng et al., 2020) 1 1 0 1 1 1 1 0 6 Moderate 
33 (J. Wu et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
34 (Kui Liu et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
35 (Niu et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
36 (X.-Y. Zhao et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
37 (B. Y. Yang et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
38 (Yafei Wang et al., 
2020j) 
0 1 0 1 2 1 1 0 6 Moderate 
39 (Mo et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
40 (Yang Xu et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
41 (Yu et al., 2020b) 1 1 0 1 1 1 1 1 7 Low 
42 (Dawei Wang et al., 
2020b) 
0 1 1 1 1 0 1 0 5 Moderate 
43 (X. Yang et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
44 (F. Zhou et al., 2020) 1 1 1 1 1 1 1 1 8 Low 
45 (T. Xu et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
46 (G. Zhang et al., 2020) 0 1 0 1 2 1 1 0 6 Moderate 
47 (J. Cao et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
48 (Wan et al., 2020) 0 1 0 1 2 1 1 0 6 Moderate 
49 (Zhongliang Wang et 
al., 2020k) 
0 1 1 1 1 0 1 0 5 Moderate 
50 (K. Liu et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
51 (C. Huang et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
52 (Yonghao Xu et al., 
2020) 
0 1 1 1 1 1 1 0 6 Moderate 
53 (Jun Chen et al., 2020) 1 1 0 1 1 1 1 1 7 Low 
54 (Xiao Li et al., 2020h) 0 1 0 1 2 1 1 0 6 Moderate 
55 (S. Qi et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
56 (Lang Wang et al., 
2020e) 
1 1 1 1 1 1 1 0 7 Low 
57 (C.-Y. Song et al., 
2020) 
0 1 0 1 2 1 1 0 6 Moderate 
58 (Ticinesi et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
59 (C. Qin et al., 2020b) 1 1 1 1 1 1 1 0 7 Low 
60 (F. Song et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
61 (Nanshan Chen et al., 
2020) 
0 1 0 1 2 1 1 0 6 Moderate 
62 (Peng Chen et al., 
2020) 
0 1 0 1 2 1 1 0 6 Moderate 
63 (Shahriarirad et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 




65 (Han et al., 2020) 0 1 0 1 2 1 1 0 6 Moderate 
66 (Jin et al., 2020) 1 1 1 1 1 1 1 0 7 Low 
67 (X. Zhang et al., 2020) 0 1 1 1 2 1 1 0 7 Low 
68 (García‐Azorín et al., 
2020) 
0 1 1 1 1 1 1 0 6 Moderate 
69 (Tao et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
70 (Jitian Li et al., 2020b) 0 1 0 1 1 1 1 0 5 Moderate 
71 (G. Zhang et al., 2020) 0 1 0 1 2 1 1 0 6 Moderate 
72 (Nie et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
73 (Imam et al., 2020) 1 1 1 1 2 1 1 0 8 Low 
74 (Kluytmans-van den Bergh 
et al., 2020) 
0 1 1 1 1 1 1 0 6 Moderate 
75 (Wei Zhao et al., 
2020) 
0 0 1 1 2 1 1 0 6 Moderate 
76 (C. Wu et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
77 (Chang et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
78 (H. Sun et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
79 (S. M. Shi et al., 2020) 0 0 1 1 2 1 1 0 6 Moderate 
80 (D. J. Lee et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
81 (Easom et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
82 (Alvarado et al., 2020) 1 1 1 1 1 1 1 0 7 Low 
83 (X. Zhao et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
84 (Kunhua Li et al., 
2020) 
0 1 1 1 1 1 1 0 6 Moderate 
85 (X. Wang et al., 2020) 1 1 0 1 1 1 1 1 7 Low 
86 (Javanian et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
87 (Kim et al. 2020) 0 1 1 1 1 1 1 0 6 Moderate 
88 (Berenguer et al., 
2020) 
1 1 1 1 2 1 1 0 8 Low 
89 (Maechler et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
90 (Koleilat et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
91 (K. Wang et al., 
2020d) 
0 1 1 1 1 0 1 0 5 Moderate 
92 (Wei Wang et al., 
2020i) 
0 1 1 1 1 1 1 0 6 Moderate 
93 (M. Huang et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
94 (J. Li et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
95 (Menglong Wang et 
al., 2020f) 
1 1 1 1 1 1 1 0 7 Low 
96 (Ke et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
97 (Jinpeng Li et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
98 (Xiaochen Li et al., 
2020i) 
0 1 1 1 1 1 1 0 6 Moderate 
99 (Brendish et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 




101 (Akbariqomi et al., 
2020) 
0 1 1 1 1 1 1 0 6 Moderate 
102 (Vandercam et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
103 (Fang-fang Chen et al., 
2020) 
1 1 1 1 1 1 1 0 7 Low 
104 (Ying Sun et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
105 (Ruirui Wang et al., 
2020g) 
0 1 1 1 1 0 1 0 5 Moderate 
106 (X. Chen et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
107 (J. yeon Lee et al., 
2020) 
1 1 1 1 1 1 1 0 7 Low 
108 (Zheng et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
109 (J. Tian et al., 2020) 1 1 1 1 2 1 1 0 8 Low 
110 (K. Yang et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
111 (Akter et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
112 (Yu et al., 2020a) 1 1 1 1 1 1 1 0 7 Low 
113 (Al-Omari et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
114 (Samrah et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
115 (Almazeedi et al., 
2020) 
1 1 1 1 1 1 1 0 7 Low 
116 (Ruan et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
117 (Peng et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
118 (S Wang et al., 2020h) 0 1 1 1 1 0 1 0 5 Moderate 
119 (Nouri-Vaskeh et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
120 (Khan et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
121 (L. Liu et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
122 (Jing Li et al., 2020b) 0 1 0 1 1 1 1 0 5 Moderate 
123 (Zhaowei Chen et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
124 (Q. Shi et al., 2020b) 0 1 1 1 1 0 1 0 5 Moderate 
125 (J. Liu et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
126 (Jingli Chen et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
127 (T. Yao et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
128 (Chen et al. 2020) 0 1 1 1 1 1 1 0 6 Moderate 
129 (W. Zhao et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
130 (Wen et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
131 (Fu et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
132 (P. Shi et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
133 (Alshukry et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
134 (Duan et al., 2020) 0 1 0 1 2 1 1 0 6 Moderate 
135 (Ayed et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
136 (Nagura-Ikeda et al., 
2020) 
0 1 0 1 2 1 1 0 6 Moderate 




138 (Yan et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
139 (Guozhen Li et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
140 (Guan et al., 2020) 1 1 1 1 2 1 1 0 8 Low 
141 (Cai et al., 2020, p. 19) 0 1 1 1 1 0 1 0 5 Moderate 
142 (Y. Xie et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
143 (M. Zhao et al., 2020) 1 1 1 1 1 1 1 0 7 Low 
144 (Lai et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
145 (Favà et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
146 (J.-J. Zhang et al., 
2020a) 
0 1 0 1 1 1 1 0 5 Moderate 
147 (W. Shi et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
148 (Z. Huang et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
149 (Bergquist et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
150 (Jalili et al., 2020) 1 1 1 1 1 1 1 0 7 Low 
151 (Xiaoping Chen et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
152 (Yinxiaohe Sun et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
153 (Jing Chen et al., 
2020) 
1 1 1 1 1 1 1 0 7 Low 
154 (Perez-Guzman et al., 
2020) 
0 1 1 1 1 1 1 0 6 Moderate 
155 (X. Liu et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
156 (Yuhong Chen et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
157 (Sepulchre et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
158 (Fuyang Chen et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
159 (S.-P. Dai et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
160 (M. K. Kim et al., 
2020) 
1 1 1 1 1 1 1 0 7 Low 
161 (Y. Zhang et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
162 (Y. Yan et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
163 (X. Yao et al., 2020) 1 1 1 1 1 1 1 0 7 Low 
164 (Jing Li et al., 2020a) 0 1 0 1 1 1 1 0 5 Moderate 
165 (J. Zhou et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
166 (J. Zhang et al., 2020) 1 1 1 1 1 1 1 0 7 Low 
167 (Steinmeyer et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
168 (Zerah et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
169 (Ramos-Rincon et al., 
2020) 
1 1 1 1 2 1 1 0 8 Low 
170 (G.-Q. Qian et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 




172 (G. Yang et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
173 (Mohamud et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
174 (Khraise et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
175 (Peng Yudong et al., 
2020) 
0 1 1 1 1 0 1 0 5 Moderate 
176 (Myers et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
177 (Barry et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
178 (Almalki et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
179 (Chu et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
180 (J. Xie et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
181 (Gayam et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
182 (Shu et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
183 (Lechien et al., 2020) 1 1 1 1 1 1 1 0 7 Low 
184 (Z. Cao et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
185 (Lapostolle et al., 
2020) 
0 1 1 1 1 1 1 0 6 Moderate 
186 (Ruoqing Li et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
187 (Casas-Rojo et al., 
2020) 
1 1 1 1 2 1 1 0 8 Low 
188 (Z. Zhou et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
189 (X. Qi et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
190 (Medetalibeyoglu et 
al., 2020) 
0 1 1 1 1 1 1 0 6 Moderate 
191 (Song et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
192 (Aibin Wang et al., 
2020a) 
0 1 0 1 1 1 1 0 5 Moderate 
193 (Y. He et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
194 (Killerby et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
195 (Price-Haywood et al., 
2020) 
1 1 1 1 1 1 1 0 7 Low 
196 (Nowak et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
197 (Izquierdo et al., 2020) 1 1 1 1 2 1 1 0 8 Low 
198 (Vena et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
199 (W. Yang et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
200 (Tomlins et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
201 (Du et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
202 (Yang Wang et al., 
2020) 
0 1 0 1 1 1 1 0 5 Moderate 
203 (J. Zhang et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
204 (Feng et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
205 (S. He et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
206 (Ji et al., 2020) 0 1 1 1 1 1 1 0 6 Moderate 
207 (X. Qin et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 




209 (Ming Chen et al., 
2020) 
0 1 1 1 1 1 1 0 6 Moderate 
210 (Yi Wang et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
211 (C. Qin et al., 2020a) 1 1 1 1 1 1 1 0 7 Low 
212 (Popov et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
213 (Zhong et al., 2020) 0 1 1 1 1 0 1 0 5 Moderate 
214 (Xiong et al., 2020) 0 1 0 1 1 1 1 0 5 Moderate 
215 (Jiang-shan Lian et al., 
2020) 
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